4-((3-Bromo-4-hydroxy-5-methoxybenzylidene)amino)-3-(3-chlorophenyl)-1H-1,2,4-triazole-5(4H)-thione

Catalog No. :
ACVOJN239
CAS No. :
478255-24-2
Molecular Formula :
C16H12BrClN4O2S
Molecular Weight :
439.72

IUPAC Name:(E)-4-((3-bromo-4-hydroxy-5-methoxybenzylidene)amino)-5-(3-chlorophenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione

4-((3-Bromo-4-hydroxy-5-methoxybenzylidene)amino)-3-(3-chlorophenyl)-1H-1,2,4-triazole-5(4H)-thione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-((3-Bromo-4-hydroxy-5-methoxybenzylidene)amino)-3-(3-chlorophenyl)-1H-1,2,4-triazole-5(4H)-thione
IUPAC Name(E)-4-((3-bromo-4-hydroxy-5-methoxybenzylidene)amino)-5-(3-chlorophenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione
MDL No.MFCD03675932
Molecular FormulaC16H12BrClN4O2S
Molecular Weight439.72
SMILESS=C1NN=C(C2=CC=CC(Cl)=C2)N1/N=C/C3=CC(OC)=C(O)C(Br)=C3
InChI KeyRBKQCQCTUFTYFR-UFWORHAWSA-N
Synonym(E)-2-bromo-4-(((3-(3-chlorophenyl)-5-mercapto-4H-1,2,4-triazol-4-yl)imino)methyl)-6-methoxyphenol;SALOR-INT L229970-1EA;2-BR-4-(((3-(3-CL-PH)-5-MERCAPTO-4H-1,2,4-TRIAZOL-4-YL)IMINO)ME)-6-METHOXYPHENOL;3H-1,2,4-Triazole-3-thione, 4-[[(3-bromo-4-hydroxy-5-methoxyphenyl)methylene]amino]-5-(3-chlorophenyl)-2,4-dihydro-
CAS No.478255-24-2

Synthetic Route by SureRoute

1. ACVOJN239 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVOJN239 route product structure diagram
    ACVOJN239478255-24-2
Inquiry

2. ACVOJN239 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVOJN239 route product structure diagram
    ACVOJN239478255-24-2
Inquiry

Comments (0)